Please check your internet connection and try again.
# Walethmade%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide
## Overview
Walethmade%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is a potassium bromide salt.
## Primary Indications
Potassium bromide is primarily used as an anticonvulsant in veterinary medicine, particularly in dogs for seizure management when other anticonvulsants are ineffective or not tolerated. Its use in human medicine is very limited and generally not recommended due to safety concerns and availability of better alternatives.
## Adult Dosing
Not applicable for human use.
## Pediatric Dosing
Not applicable for human use.
## Dose Adjustments
Not applicable for human use.
## Contraindications
Not applicable for human use.
## Adverse Effects
If used in animals, potential adverse effects include sedation, ataxia, pancreatitis, and hyperkalemia.
## Key Drug Interactions
Not applicable for human use.
## Monitoring
Not applicable for human use.
## Clinical Pearls
Potassium bromide is not considered a first-line treatment for epilepsy in humans due to its narrow therapeutic index, potential for toxicity, and the availability of safer and more effective antiepileptic drugs.
***
*Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider to verify current prescribing information and for any questions regarding your specific medical condition or treatment.*